Long-range wireless charging enables devices to charge several feet or meters using radio frequency (RF) systems and resonant inductive coupling. This technology offers convenience by eliminating cables, enhances safety, and reduces clutter.

The generative AI market is experiencing unprecedented growth, largely driven by advancements in large language models (LLMs) such as OpenAI's GPT series and Google's BERT.

The advent of organ-on-chip (OOC) technology has disrupted biomedical research, offering never-before-imagined opportunities to study human organ systems in vitro with remarkable accuracy.

In recent years, the increasing prevalence of chronic diseases such as cardiovascular disorders and diabetes has led to a surge in the demand for advanced drug delivery systems that enable patients to self-administer their medications.

Tattoos and body art in the U.S. have soared in popularity lately, especially amongst Millennials and Gen Z, fueling an industry comprised of 11,600 tattoo studios. The industry, which also includes tattoo removal services, is estimated to be worth $4.5 billion, and is growing strongly.

The total medical aesthetic market is estimated to have grown to a peak of USD 34.6 billion in 2023, boosted by rising preferences for aesthetic appearances.

The convergence of agriculture and renewable energy is an emerging paradigm in sustainable development. In recent years, agrivoltaics, combining solar power with agricultural activities, has gained significant traction.

The use of big data analytical tools offers enormous opportunities to collect large amounts of data for the development of therapeutic drugs. Big data in healthcare typically refers to data collection from different sources, including biometric systems, medical research, data analytical tools, and electronic medical records.

The identity verification market is booming, driven by the digitalization of services and rising security concerns. With a projected value of $13.45 billion in 2024 and a CAGR of 12.44%, the market is expected to reach $43.45 billion by 2034.

The cancer biomarker market has witnessed substantial growth in recent years, and according to market analysis, it is poised to reach $22.77 billion in 2024 from $19.74 billion in 2023, reflecting a compound annual growth rate (CAGR) of 15.4%.